Sudhir B Malla

11PUBLICATIONS
88CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 19, 2026
Immune and stromal tumour biology associated with neoadjuvant radiotherapy response in locally advanced rectal cancer.

|Jul 23, 2026
Mitochondrial metabolism determines chemotherapy sensitivity in colorectal cancer.

|May 26, 2026
Viral mimicry redirects immunosuppressed colorectal tumour landscapes towards a proinflammatory and CMS1-like regenerative state.

|Dec 18, 2025
Nucleophosmin supports WNT-driven hyperproliferation and tumor initiation.

Georgios Kanellos, Chiara Giacomelli, Alexander Raven

|Jun 04, 2025
Loss of colonic fidelity enables multilineage plasticity and metastasis.

Patrizia Cammareri, Michela Raponi, Yourae Hong

|Jun 03, 2024
Author Correction: Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer.

Sudhir B Malla, Ryan M Byrne, Maxime W Lafarge

Pageof 2

Frequent Collaborators

10 joint publications

Philip D Dunne

8 joint publications

Owen Sansom

6 joint publications

Raheleh Amirkhah

6 joint publications

Andrew D Campbell